年老时的肌肉减少症，肥胖症，骨质疏松症

摘要

这篇文章介绍了关于老年人身体结构的当今概念。特别要注意肌肉减少症的可能原因和致病方面，以及对它熟知的现代诊断方法。衰老过程不可避免地与身体结构的各种变化结合在一起。这种与年龄有关的变化可以通过三个主要过程来描述：骨骼组织的生长和矿物质密度的降低（骨质减少和骨质疏松）；肌肉质量逐渐下降；脂肪组织的增加（肌肉减少症和肌肉减少肥胖症），并其重新分配给中央和心脏脂肪蓄积。肌肉减少症和骨质疏松症被认为是主要的老年综合症。这些病理状况极大地降低了老年人的生活质量；为无法自理的老年人提供生活环境，需要长期护理，增加住院频率，并分析最后导致不良的原因。

1. JafariNasabian P., Inglis J.E., Reilly W., et al. Aging human body: Changes in bone, muscle and body fat with consequent changes in nutrient intake. J Endocrinol. 2017; 234(1): R37–51. https://doi.org/10.1530/JOE-16-0603 PMID: 28442508

2. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010; 39(4): 412–23. https://doi.org/10.1093/ageing/afq034 PMID: 20392703

3. Cruz-Jentoft A.J., Bahat G., Bauer J., et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(1): 16–31. https://doi.org/10.1093/ageing/afy169 PMID: 31081853

4. Schaap L.A., Van Schoor N.M., Lips P., Visser M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: The longitudinal aging study Amsterdam. J Gerontol A Biol Sci Med Sci. 2018; 73(9): 1199–204. https://doi.org/10.1093/gerona/glx245 PMID: 29300839

5. Fielding R. A., Vellas B., Evans W.J., et al. Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc. 2011; 12(4): 249–56. https://doi.org/10.1016/j.jamda.2011.01.003 PMID: 21527165

6. Walston J.D. Sarcopenia in older adults. Curr Opin Rheumatol. 2012; 24(6): 623–7. https://doi.org/10.1097/BOR.0b013e328358d59b PMID: 22955023

7. Antunes A.C., Araújo D.A., Veríssimo M.T., Amaral T.F. Sarcopenia and hospitalisation costs in older adults: a cross-sectional study. Nutr Diet. 2017; 74(1): 46–50. https://doi.org/10.1111/1747-0080.12287 PMID: 28731551

8. Steffl M., Sima J., Shiells K., Holmerova I. The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: Results from the survey of health, ageing and retirement in Europe (SHARE). Clin Interv Aging. 2017; 12: 2003–7. https://doi.org/10.2147/CIA.S150826 PMID: 29225462

9. Lee K., Shin Y., Huh J., et al. Recent issues on body composition imaging for sarcopenia evaluation. Korean J Radiol. 2019; 20(2): 205–17. https://doi.org/10.3348/kjr.2018.0479 PMID: 30672160

10. Keller K., Engelhardt M. Strength and muscle mass loss with aging process. Age and strength loss. Muscles Ligaments Tendons J. 2013; 3(4): 346–50. https://doi.org/10.11138/mltj/2013.3.4.346 PMID: 24596700

11. Ilich J.Z., Kelly O.J., Inglis J.E., et al. Interrelationship among muscle, fat, and bone: Connecting the dots on cellular, hormonal, and whole body levels. Ageing Res Rev. 2014; 15: 51–60. https://doi.org/10.1016/j.arr.2014.02.007 PMID: 24632496

12. Pedersen B.K., Fischer C.P. Beneficial health effects of exercise — the role of IL-6 as a myokine. Trends Pharmacol Sci. 2007; 28(4): 152–6. https://doi.org/10.1016/j.tips.2007.02.002 PMID: 17331593

13. Kelly M., Gauthier M., Saha A.K., Ruderman N.B. Activation of AMP-Activated Protein Kinase by Interleukin-6 in Rat Skeletal Muscle. Diabetes. 2009; 58(9): 1953–60. https://doi.org/10.2337/db08-1293 PMID: 19502419

14. Morley J.E. Sarcopenia in the elderly. Fam Pract. 2012; 29(suppl. 1): i44–8. https://doi.org/10.1093/fampra/cmr063 PMID: 22399555

15. Sayer A.A., Robinson S.M., Patel H.P., et al. New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing. 2013; 42(2): 145–50. https://doi.org/10.1093/ageing/afs191 PMID: 23315797

16. Jo E., Lee S.R., Park B.S., Kim J.S. Potential mechanisms underlying the role of chronic inflammation in age-related muscle wasting. Aging Clin Exp Res. 2012; 24(5): 412–22. https://doi.org/10.3275/8464 PMID: 22717404

17. Kalinkovich A., Livshits G. Sarcopenia — The search for emerging biomarkers. Ageing Res Rev. 2015; 22: 58–71. https://doi.org/10.1016/j.arr.2015.05.001 PMID: 25962896

18. Armand A.S., Laziz I., Dieghloul D., et al. Apoptosis-inducing factor regulates skeletal muscle progenitor cell number and muscle phenotype. PLoS One. 2011; 6(11): e27283. https://doi.org/10.1371/journal.pone.0027283 PMID: 22076146

19. Collins-Hooper H., Woolley T.E., Dyson L., et al. Age-related changes in speed and mechanism of adult skeletal muscle stem cell migration. Stem Cells. 2012; 30(6): 1182–95. https://doi.org/10.1002/stem.1088 PMID: 22593017

20. Mijnarends D.M., Koster A., Schols J.M., et al. Physical activity and incidence of sarcopenia: The population-based AGES-Reykjavik Study. Age Ageing. 2016; 45(5): 614–20. https://doi.org/10.1093/ageing/afw090 PMID: 27189729

21. Muscaritoli M., Anker S.D., Argiles J., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010; 29(2): 154–9. https://doi.org/10.1016/j.clnu.2009.12.004 PMID: 20060626

22. Beaudart C., McCloskey E., Bruyère O., et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016; 16(1): 170. https://doi.org/10.1186/s12877-016-0349-4 PMID: 27716195

23. Gonzalez M.C., Heymsfield S.B. Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? J Cachexia Sarcopenia Muscle. 2017; 8(2): 187–9. https://doi.org/10.1002/jcsm.12159 PMID: 28145079

24. Cooper C., Fielding R., Visser M.V., et al. Tools in the assessment of sarcopenia. Calcif Tissue Int. 2013; 93(3): 201–10. https://doi.org/10.1007/s00223-013-9757-z PMID: 23842964

25. Santoro A., Bazzocchi A., Guidarelli G., et al. A cross-sectional analysis of body composition among healthy elderly from the European NU-AGE study: Sex and country specific features. Front Physiol. 2018; 9: 1693. https://doi.org/10.3389/fphys.2018.01693 PMID: 30555339

26. Tchkonia T., Morbeck D.E., Von Zglinicki T., et al. Fat tissue, aging, and cellular senescence. Aging Cell. 2010; 9(5): 667–84. https://doi.org/10.1111/j.1474-9726.2010.00608.x PMID: 20701600

27. Mantovani G. Cachexia and Wasting: A Modern Approach. Pathophysiology of Body Composition Changes in Elderly People. Milan: Springer, 2006: 369–76.

28. Cheng F.W., Gao X., Jensen G.L. Weight Change and All-Cause Mortality in Older Adults: A Meta-Analysis. J Nutr Gerontol Geriatr. 2015; 34(4): 343–68. https://doi.org/10.1080/21551197.2015.1090362 PMID: 26571354

29. Lisko I., Tiainen K., Stenholm S., et al. Inflammation, adiposity, and mortality in the oldest old. Rejuvenation research. 2012; 15(5): 445–52. https://doi.org/10.1089/rej.2011.1310 PMID: 22998329

30. Pedersen M., Bruunsgaard H., Weis N., et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev. 2003; 124(4): 495–502. https://doi.org/10.1016/S0047-6374(03)00027-7 PMID: 12714258

31. Bazzocchi A., Diano D., Ponti F., et al. Health and ageing: A cross-sectional study of body composition. Clin. Nutr. 2013; 32(4): 569–78. https://doi.org/10.1016/j.clnu.2012.10.004 PMID: 23111003

32. Kyle U.G., Genton L., Hans D., et al. Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur. J. Clin. Nutr. 2001; 55(8): 663–72. https://doi.org/10.1038/sj.ejcn.1601198 PMID: 11477465

33. Hughes V.A., Frontera W.R., Roubenoff R., et al. Longitudinal changes in body composition in older men and women: Role of body weight change and physical activity. Am. J. Clin. Nutr. 2002; 76(2): 473–81. https://doi.org/10.1093/ajcn/76.2.473 PMID: 12145025

34. Pararasa C., Bailey C.J., Griffiths H.R. Ageing, adipose tissue, fatty acids and inflammation. Biogerontology. 2015; 16(2): 235–48. https://doi.org/10.1007/s10522-014-9536-x PMID: 25367746

35. Mancuso P., Bouchard B. The impact of aging on adipose function and adipokine synthesis. Front Endocrinol. 2019; 10: 137. https://doi.org/10.3389/fendo.2019.00137 PMID: 30915034

36. Rost S., Freuer D., Peters A., et al. New indexes of body fat distribution and sex-specific risk of total and cause-specific mortality: A prospective cohort study. BMC Public Health. 2018; 18(1): 427. https://doi.org/10.1186/s12889-018-5350-8 PMID: 29609587

37. Hunter G.R., Gower B. A., Kane B.L. Age related shift in visceral fat. Int. J. Body Compos. Res. 2010; 8(3): 103–8. PMID: 24834015

38. Henche S.A., Torres R.R., Pellico L.G. An evaluation of patterns of change in total and regional body fat mass in healthy Spanish subjects using dual-energy X-ray absorptiometry (DXA). Eur. J. Clin. Nutr. 2008; 62(12): 1440–8. https://doi.org/10.1038/sj.ejcn.1602883 PMID: 17717537

39. Coin A., Giannini S., Minicuci N., et al. Limb fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old italian population. Clin. Nutr. 2012; 31(4): 506–11. https://doi.org/10.1016/j.clnu.2012.01.012 PMID: 22342050

40. International Osteoporosis Foundation (IOF). Lesnyak O, Nauroy L. The Eastern European & Central Asian regional audit epidemiology, costs & burden of osteoporosis in 2010. International Osteoporosis Foundation; 2010: 43–8. URL: https://www.osteoporosis.foundation/sites/iofbonehealth/files/2019-06/2010_Eastern_European_Central_Asian_Audit_English.pdf (дата обращения: 13.06.2020).

41. Pietschmann P., Rauner M., Sipos W., Kerschan-Schindl K. Osteoporosis: An age-related and gender-specific disease — A mini-review. Gerontology. 2009; 55(1): 3–12. https://doi.org/10.1159/000166209 PMID: 18948685

42. Khosla S., Melton L.J., Riggs B.L. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed? J Bone Miner Res. 2011; 26(3): 441–51. https://doi.org/10.1002/jbmr.262 PMID: 20928874

43. Wijnands J. M., Boonen A., Dagnelie P.C., et al. The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: The CODAM study. Rheumatol. (United Kingdom). 2014; 53(11): 2053–62. https://doi.org/10.1093/rheumatology/keu239 PMID: 24917566

44. Katz J.D., Walitt B. Rheumatic diseases in older adults. Rheum Dis Clin North Am. 2018; 44(3): XIII–XIV. https://doi.org/10.1016/j.rdc.2018.05.001 PMID: 30001792

45. Szulc P., Bouxsein M.L., Compston J.E. Overview of osteoporosis: Epidemiology and clinical management. Nyon, Switzerland: International Osteoporosis Foundation. 2011: 65. https://www.researchgate.net/publication/313894090_Overview_of_osteoporosis_epidemiology_and_clinical_management (дата обращения: 13.06.2020).

46. Kaufman J. M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005; 26(6): 833–76. https://doi.org/10.1210/er.2004-0013 PMID: 15901667

47. Khosla S., Amin S., Orwoll E. Osteoporosis in men. Endocr Rev. 2008; 29(4): 441–64. https://doi.org/10.1210/er.2008-0002 PMID: 18451258

48. Kuroshima S., Kaku M., IshimotoT., et al. A paradigm shift for bone quality in dentistry: A literature review. J Prosthodont Res. 2017; 61(4): 353–62. https://doi.org/10.1016/j.jpor.2017.05.006 PMID: 28633987

49. Annweiler C., Montero-Odasso M., Schott A.M., et al. Fall prevention and vitamin D in the elderly: An overview of the key role of the non-bone effects. J Neuroeng Rehabil. 2010; 7(1): 50. https://doi.org/10.1186/1743-0003-7-50 PMID: 20937091

50. Bird M.-L., Haber N.E., Batchelor F., et al. Vitamin D and parathyroid hormone are associated with gait instability and poor balance performance in mid-age to older aged women. Gait Posture. 2018; 59: 71–5. https://doi.org/10.1016/j.gaitpost.2017.09.036 PMID: 29017107

51. Vandenbroucke A., Luyten F.P., Flamaing J., Gielen E. Pharmacological treatment of osteoporosis in the oldest old. Clin. Interv. Aging. 2017; 12: 1065–77. https://doi.org/10.2147/CIA.S131023 PMID: 28740372

52. Gielen E., Bergmann P., Bruyère, O., et al. Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club. Calcif. Tissue Int. 2017; 101(2): 111–31. https://doi.org/10.1007/s00223-017-0266-3 PMID: 28324124

53. Tom S.E., Adachi J.D., Anderson F.A. Jr., et al. Frailty and fracture, disability, and falls: A multiple country study from the global longitudinal study of osteoporosis in women. J. Am. Geriatr. Soc. 2013; 61(3): 327–34. https://doi.org/10.1111/jgs.12146 PMID: 23351064

54. Reiss J., Iglseder B., Alzner R., et al. Sarcopenia and osteoporosis areinterrelated in geriatric inpatients. Z. Gerontol. Geriatr. 2019; 52(7): 688–93. https://doi.org/10.1007/s00391-019-01553-z PMID: 31049683

55. Santos V.R.D., Christofaro D.G.D., Gomes I.C., et al. Relationship between obesity, sarcopenia, sarcopenic obesity, and bone mineral density in elderly subjects aged 80 years and over. Rev. Bras. Ortop. 2018; 53(3): 300–5. https://doi.org/10.1016/j.rbo.2017.05.010 PMID: 29892580

56. Ho-Pham L.T., Nguyen U.D.T., Nguyen T.V. Association between lean mass, fat mass, and bone mineral density: A meta-analysis. J. Clin. Endocrinol. Metab. 2014; 99(1): 30–8. https://doi.org/10.1210/jc.2013-3190 PMID: 24384013

57. Marwaha R.K., Garg M.K., Tandon N., et al. Relationship of body fat and its distribution with bone mineral density in Indian population. J. Clin. Densitom. 2013; 16(3): 353–9. https://doi.org/10.1016/j.jocd.2012.08.074 PMID: 23910719

58. Liu P.Y., Ilich J.Z., Brummel-SmithK., Ghosh S. New insight into fat, muscle and bone relationship in women: determining the threshold at which body fat assumes negative relationship with bone mineral density. Int. J. Prev. Med. 2014; 5(11): 1452–63. PMID: 25538842

59. Kaji H. Linkage between muscle and bone: Common catabolic signals resulting in osteoporosis and sarcopenia. Current Opinion in Clinical Nutrition and Metabolic Care. 2013; 16(3): 272–7. https://doi.org/10.1097/MCO.0b013e32835fe6a5 PMID: 23481148